- 85,000+ IDF soldiers receiving psychological treatment since October 7
- 60% of soldiers in rehabilitation centers diagnosed with PTSD
- 1 in 3 Israelis showing PTSD symptoms
- 1 caseworker for every 850 veterans — a catastrophic shortage
- 180% projected increase in PTSD cases by 2028
- 21 IDF soldier suicides in 2024 — the highest in a decade
A Nation in Trauma
On October 7, 2023, Hamas carried out the deadliest attack on Jewish people since the Holocaust. Over 1,200 Israelis were murdered, more than 250 were taken hostage, and thousands more were injured. The communities of the Gaza Envelope — kibbutzim and towns that had been home to thousands of families — were devastated.
What followed was a prolonged military campaign that has drawn hundreds of thousands of reservists into combat, kept communities under constant rocket fire, and left an entire nation in a state of sustained collective trauma. The psychological wound of October 7 is not healing — it is deepening.
The Numbers Tell a Devastating Story
Israel's Defense Ministry has documented a nearly 40% increase in PTSD cases among its soldiers since September 2023, with projections suggesting the figure will rise by 180% by 2028. Of the approximately 22,300 troops currently treated for war wounds, 60% are suffering from PTSD and other psychological conditions.
By December 2025, the total number of soldiers receiving psychological treatment had reached 85,000 — a figure that, by the Defense Ministry's own estimates, will grow by another 10,000 in 2026 alone. The ministry's rehabilitation budget stands at NIS 8.3 billion, with NIS 4.1 billion — half — allocated to mental health. Yet the demand is so overwhelming that one therapist is managing up to 750 patients in some regions.
"More than half a million Israelis are at high risk of developing post-trauma, including those directly exposed to terrorism, soldiers in combat, and civilians within 80 kilometers of Gaza." — Boaz Wachtel
The Failure of Conventional Treatment
Standard PTSD treatment protocols — cognitive processing therapy, prolonged exposure therapy, EMDR, SSRIs — work for many people. But they require repeated sessions over months or years, and they fail a significant proportion of patients with treatment-resistant or severe PTSD. For soldiers and survivors dealing with the compound trauma of October 7, conventional approaches are demonstrably insufficient.
The number of reservists seeking psychological assistance has soared from approximately 270 per year before the war to around 3,000 annually. NATAL's crisis helplines received over 53,000 calls. Suicides among combat soldiers in 2024 reached their highest level in over a decade. Of those soldiers who took their own lives, only 17% had met with a mental health officer in the two months before their death.
Why Ibogaine Is the Answer
The Stanford study of 2024 demonstrated that a single ibogaine treatment session produces an 88% reduction in PTSD symptoms, an 87% reduction in depression, and an 81% reduction in anxiety — one month later. These are not incremental improvements. These are transformative, life-altering changes achieved in a single intervention.
For a country facing an overwhelming, decade-long wave of trauma with a catastrophic shortage of therapists and treatment facilities, ibogaine's rapid efficacy is not just appealing — it is potentially the only realistic solution at scale. One treatment session per patient, administered safely under medical supervision, could reach thousands of veterans far more quickly than any conventional protocol.
The Path Forward
Israel has the scientific infrastructure, the medical expertise, and the lived urgency to become a world leader in ibogaine-assisted therapy. The Ibogaine Foundation of Israel is calling for:
- Fast-tracked regulatory review of ibogaine for PTSD and TBI under Israel's Health Ministry
- Government funding for clinical trials, building on the Stanford evidence base
- Establishment of medically supervised ibogaine treatment centers for veterans and survivors
- International research collaboration with institutions like Stanford, UT Austin, and Baylor College of Medicine
- Public education to reduce stigma around psychedelic-assisted therapy among soldiers and their families
The time to act is not tomorrow. It is now.